{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26457296", "DateCompleted": {"Year": "2016", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "09", "Day": "17"}], "ELocationID": ["120679", "10.1155/2015/120679"], "Language": ["eng"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2015", "PubDate": {"Year": "2015"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.", "Pagination": {"StartPage": "120679", "MedlinePgn": "120679"}, "Abstract": {"AbstractText": ["Obesity and overeating are among the most prevalent health concerns worldwide and individuals are increasingly using performance and image-enhancing drugs (PIEDs) as an easy and fast way to control their weight. Among these, herbal weight-loss products (HWLPs) often attract users due to their health claims, assumed safety, easy availability, affordable price, extensive marketing, and the perceived lack of need for professional oversight. Reports suggest that certain HWLPs may lead to onset or exacerbation of psychiatric disturbances. Here we review the available evidence on psychiatric adverse effects of HWLPs due to their intrinsic toxicity and potential for interaction with psychiatric medications."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy ; School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK."}], "LastName": "Bersani", "ForeName": "F Saverio", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy."}], "LastName": "Coviello", "ForeName": "Marialuce", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Sciences, European University of Rome, 00163 Rome, Italy."}], "LastName": "Imperatori", "ForeName": "Claudio", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy."}], "LastName": "Francesconi", "ForeName": "Marta", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, University of California San Francisco, San Francisco, CA 94143, USA."}], "LastName": "Hough", "ForeName": "Christina M", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy ; School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK ; Department of Psychiatry, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden."}], "LastName": "Valeriani", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy."}], "LastName": "De Stefano", "ForeName": "Gianfranco", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Association for Applied Human Sciences, 00100 Rome, Italy."}], "LastName": "Bolzan Mariotti Posocco", "ForeName": "Flaminia", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK ; Department of Neuroscience and Imaging, Gabriele D'Annunzio University, 66100 Chieti, Italy."}], "LastName": "Santacroce", "ForeName": "Rita", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology and Psychiatry, Sapienza University of Rome, 00185 Rome, Italy."}], "LastName": "Minichino", "ForeName": "Amedeo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK."}], "LastName": "Corazza", "ForeName": "Ornella", "Initials": "O"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Obesity Agents"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Anti-Obesity Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced", "epidemiology"], "DescriptorName": "Mental Disorders"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Corazza O., Assi S., Simonato P., et al. Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology. 2013;28(4):317\u2013323. doi: 10.1002/hup.2299.", "ArticleIdList": ["10.1002/hup.2299", "23881879"]}, {"Citation": "Schifano F., Orsolini L., Duccio Papanti G., Corkery J. M. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15\u201326. doi: 10.1002/wps.20174.", "ArticleIdList": ["10.1002/wps.20174", "PMC4329884", "25655145"]}, {"Citation": "Bersani F. S., Corazza O., Albano G., et al. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International. 2014;2014:6. doi: 10.1155/2014/734749.734749", "ArticleIdList": ["10.1155/2014/734749", "PMC4106087", "25105138"]}, {"Citation": "Bersani F. S., Corazza O., Simonato P., et al. Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. General Hospital Psychiatry. 2013;35(5):571\u2013573. doi: 10.1016/j.genhosppsych.2013.04.013.", "ArticleIdList": ["10.1016/j.genhosppsych.2013.04.013", "23706777"]}, {"Citation": "Corazza O., Simonato P., Corkery J., Trincas G., Schifano F. \u2018Legal highs\u2019: safe and legal \u2018heavens\u2019? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista di Psichiatria. 2014;49(2):89\u201394. doi: 10.1708/1461.16147.", "ArticleIdList": ["10.1708/1461.16147", "24770577"]}, {"Citation": "Minichino A., Bersani F. S., Cal\u00f2 W. K., et al. Smoking behaviour and mental health disorders-mutual influences and implications for therapy. International Journal of Environmental Research and Public Health. 2013;10(10):4790\u20134811. doi: 10.3390/ijerph10104790.", "ArticleIdList": ["10.3390/ijerph10104790", "PMC3823321", "24157506"]}, {"Citation": "Santacroce R., Corazza O., Martinotti G., Bersani F. S., Valeriani G., Di Giannantonio M. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products. Human Psychopharmacology: Clinical and Experimental. 2015;30(4):265\u2013271. doi: 10.1002/hup.2410.", "ArticleIdList": ["10.1002/hup.2410", "26216561"]}, {"Citation": "Bersani F. S., Imperatori C., Prilutskaya M., Kuliev R., Corazza O. Injecting eye-drops: a mini-review on the non-clinical use of tropicamide. Human Psychopharmacology: Clinical and Experimental. 2015;30(4):262\u2013264. doi: 10.1002/hup.2481.", "ArticleIdList": ["10.1002/hup.2481", "26216560"]}, {"Citation": "Valeriani G., Corazza O., Bersani F. S., et al. Olanzapine as the ideal \u2018trip terminator\u2019? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms. Human Psychopharmacology: Clinical and Experimental. 2015;30(4):249\u2013254. doi: 10.1002/hup.2431.", "ArticleIdList": ["10.1002/hup.2431", "26216558"]}, {"Citation": "Schifano F., Corazza O., Marchi A., et al. Analysis of online reports on the potential misuse of benzidamine. Rivista di Psichiatria. 2013;48(3):182\u2013186. doi: 10.1708/1292.14286.", "ArticleIdList": ["10.1708/1292.14286", "23752801"]}, {"Citation": "Schifano F., Ricciardi A., Corazza O., et al. New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project. Rivista di Psichiatria. 2010;45(2):88\u201393.", "ArticleIdList": ["20568579"]}, {"Citation": "McVeigh J., Evans-Brown M., Bellis M. A. Human enhancement drugs and the pursuit of perfection. Adicciones. 2012;24(3):185\u2013190.", "ArticleIdList": ["22868973"]}, {"Citation": "Corazza O., Bersani F. S., Brunoro R., Valeriani G., Martinotti G., Schifano F. The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam. Substance Use and Misuse. 2014;49(14):1849\u20131856. doi: 10.3109/10826084.2014.912232.", "ArticleIdList": ["10.3109/10826084.2014.912232", "24827869"]}, {"Citation": "Corazza O., Valeriani G., Bersani F. S., et al. \u2018Spice,\u2019 \u2018kryptonite,\u2019 \u2018black mamba\u2019: an overview of brand names and marketing strategies of novel psychoactive substances on the web. Journal of Psychoactive Drugs. 2014;46(4):287\u2013294. doi: 10.1080/02791072.2014.944291.", "ArticleIdList": ["10.1080/02791072.2014.944291", "25188698"]}, {"Citation": "Field A. E., Coakley E. H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of Internal Medicine. 2001;161(13):1581\u20131586. doi: 10.1001/archinte.161.13.1581.", "ArticleIdList": ["10.1001/archinte.161.13.1581", "11434789"]}, {"Citation": "Expert Panel on the Identification-Evaluation and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. The American Journal of Clinical Nutrition. 1998;68(4):899\u2013917.", "ArticleIdList": ["9771869"]}, {"Citation": "Blanck H. M., Serdula M. K., Gillespie C., et al. Use of nonprescription dietary supplements for weight loss is common among Americans. Journal of the American Dietetic Association. 2007;107(3):441\u2013447. doi: 10.1016/j.jada.2006.12.009.", "ArticleIdList": ["10.1016/j.jada.2006.12.009", "17324663"]}, {"Citation": "Chan T. Y. K. Potential risks associated with the use of herbal anti-obesity products. Drug Safety. 2009;32(6):453\u2013456. doi: 10.2165/00002018-200932060-00002.", "ArticleIdList": ["10.2165/00002018-200932060-00002", "19459713"]}, {"Citation": "Saper R. B., Eisenberg D. M., Phillips R. S. Common dietary supplements for weight loss. American Family Physician. 2004;70(9):1731\u20131738.", "ArticleIdList": ["15554492"]}, {"Citation": "Sharpe P. A., Granner M. L., Conway J. M., Ainsworth B. E., Dobre M. Availability of weight-loss supplements: results of an audit of retail outlets in a southeastern city. Journal of the American Dietetic Association. 2006;106(12):2045\u20132051. doi: 10.1016/j.jada.2006.09.014.", "ArticleIdList": ["10.1016/j.jada.2006.09.014", "17126636"]}, {"Citation": "Hawkins N., Scott Richards P., Granley H. M., Stein D. M. The impact of exposure to the thin-ideal media image on women. Eating Disorders. 2004;12(1):35\u201350. doi: 10.1080/10640260490267751.", "ArticleIdList": ["10.1080/10640260490267751", "16864303"]}, {"Citation": "Hasani-Ranjbar S., Jouyandeh Z., Abdollahi M. A systematic review of anti-obesity medicinal plants\u2014an update. Journal of Diabetes and Metabolic Disorders. 2013;12(1, article 28) doi: 10.1186/2251-6581-12-28.", "ArticleIdList": ["10.1186/2251-6581-12-28", "PMC3914705", "23777875"]}, {"Citation": "Pittler M. H., Schmidt K., Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obesity Reviews. 2005;6(2):93\u2013111. doi: 10.1111/j.1467-789x.2005.00169.x.", "ArticleIdList": ["10.1111/j.1467-789x.2005.00169.x", "15836459"]}, {"Citation": "Coon J. T., Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety. 2002;25(5):323\u2013344. doi: 10.2165/00002018-200225050-00003.", "ArticleIdList": ["10.2165/00002018-200225050-00003", "12020172"]}, {"Citation": "Yin J., Zhang H., Ye J. Traditional Chinese medicine in treatment of metabolic syndrome. Endocrine, Metabolic and Immune Disorders\u2014Drug Targets. 2008;8(2):99\u2013111. doi: 10.2174/187153008784534330.", "ArticleIdList": ["10.2174/187153008784534330", "PMC2467395", "18537696"]}, {"Citation": "Todorov S., Zamfirova R., Petkov V. D. Study of the effects of nootropic agents on the adrenegic neurotransmission in smooth muscles of young and old animals. Acta Physiologica et Pharmacologica Bulgarica. 1990;16(1):38\u201345.", "ArticleIdList": ["2168120"]}, {"Citation": "Benishin C. G., Lee R., Wang L. C. H., Liu H. J. Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology. 1991;42(4):223\u2013229. doi: 10.1159/000138801.", "ArticleIdList": ["10.1159/000138801", "1852782"]}, {"Citation": "Attele A. S., Wu J. A., Yuan C.-S. Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology. 1999;58(11):1685\u20131693. doi: 10.1016/s0006-2952(99)00212-9.", "ArticleIdList": ["10.1016/s0006-2952(99)00212-9", "10571242"]}, {"Citation": "Siegel R. K. Ginseng abuse syndrome. Problems with the panacea. The Journal of the American Medical Association. 1979;241(15):1614\u20131615. doi: 10.1001/jama.241.15.1614.", "ArticleIdList": ["10.1001/jama.241.15.1614", "430716"]}, {"Citation": "Scaglione F., Cattaneo G., Alessandria M., Cogo R. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected] Drugs under Experimental and Clinical Research. 1996;22(2):65\u201372.", "ArticleIdList": ["8879982"]}, {"Citation": "Cartwright L. You and ginseng: recent human trials. Australian Journal of Pharmacy. 1982;62:p. 47."}, {"Citation": "Gonzalez-Seijo J. C., Ramos Y. M., Lastra I. Manic episode and ginseng: report of a possible case. Journal of Clinical Psychopharmacology. 1995;15(6):447\u2013448. doi: 10.1097/00004714-199512000-00014.", "ArticleIdList": ["10.1097/00004714-199512000-00014", "8748439"]}, {"Citation": "V\u00e1zquez I., Ag\u00fcera-Ortiz L. F. Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta Psychiatrica Scandinavica. 2002;105(1):76\u201377.", "ArticleIdList": ["12086230"]}, {"Citation": "Wilkie A., Cordess C. Ginseng\u2014a root just like a carrot? Journal of the Royal Society of Medicine. 1994;87(10):594\u2013595.", "ArticleIdList": ["PMC1294848", "7966106"]}, {"Citation": "Kim E. J. Y., Chen Y., Huang J. Q., et al. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. Journal of Ethnopharmacology. 2013;146(1):40\u201361. doi: 10.1016/j.jep.2012.12.027.", "ArticleIdList": ["10.1016/j.jep.2012.12.027", "23286904"]}, {"Citation": "Whitehouse A. M., Duncan J. M. Ephedrine psychosis rediscovered. The British Journal of Psychiatry. 1987;150(2):258\u2013261. doi: 10.1192/bjp.150.2.258.", "ArticleIdList": ["10.1192/bjp.150.2.258", "3651687"]}, {"Citation": "Greenway F. L. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obesity Reviews. 2001;2(3):199\u2013211. doi: 10.1046/j.1467-789x.2001.00038.x.", "ArticleIdList": ["10.1046/j.1467-789x.2001.00038.x", "12120105"]}, {"Citation": "Mehendale S. R., Bauer B. A., Yuan C.-S. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine. The American Journal of Chinese Medicine. 2004;32(1):1\u201310. doi: 10.1142/s0192415x04001680.", "ArticleIdList": ["10.1142/s0192415x04001680", "15154280"]}, {"Citation": "Shekelle P. G., Hardy M. L., Morton S. C., et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. The Journal of the American Medical Association. 2003;289(12):1537\u20131545. doi: 10.1001/jama.289.12.1537.", "ArticleIdList": ["10.1001/jama.289.12.1537", "12672771"]}, {"Citation": "Astrup A. Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation. Acta Endocrinologica. Supplementum. 1986;278:1\u201332.", "ArticleIdList": ["3464154"]}, {"Citation": "Maglione M., Miotto K., Iguchi M., Jungvig L., Morton S. C., Shekelle P. G. Psychiatric effects of ephedra use: an analysis of food and drug administration reports of adverse events. American Journal of Psychiatry. 2005;162(1):189\u2013191. doi: 10.1176/appi.ajp.162.1.189.", "ArticleIdList": ["10.1176/appi.ajp.162.1.189", "15625222"]}, {"Citation": "Herridge C. F., a'Brook M. F. Ephedrine psychosis. British Medical Journal. 1968;2, article 160 doi: 10.1136/bmj.2.5598.160.", "ArticleIdList": ["10.1136/bmj.2.5598.160", "PMC1989207", "5641981"]}, {"Citation": "Doyle H., Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. British Medical Journal. 1996;313(7059):p. 756.", "ArticleIdList": ["PMC2352114", "8819473"]}, {"Citation": "Jacobs K. M., Hirsch K. A. Psychiatric complications of Ma-huang. Psychosomatics. 2000;41(1):58\u201362. doi: 10.1016/S0033-3182(00)71174-1.", "ArticleIdList": ["10.1016/S0033-3182(00)71174-1", "10665269"]}, {"Citation": "Walton R., Manos G. H. Psychosis related to ephedra-containing herbal supplement use. Southern Medical Journal. 2003;96(7):718\u2013720. doi: 10.1097/01.smj.0000054913.04507.68.", "ArticleIdList": ["10.1097/01.smj.0000054913.04507.68", "12940331"]}, {"Citation": "Katz J. L. A psychotic manic state induced by an herbal preparation. Psychosomatics. 2000;41(1):73\u201374. doi: 10.1016/s0033-3182(00)71179-0.", "ArticleIdList": ["10.1016/s0033-3182(00)71179-0", "10665273"]}, {"Citation": "Boerth J. M., Caley C. F. Possible case of mania associated with ma-huang. Pharmacotherapy. 2003;23(3):380\u2013383. doi: 10.1592/phco.23.3.380.32114.", "ArticleIdList": ["10.1592/phco.23.3.380.32114", "12627938"]}, {"Citation": "Capwell R. R. Ephedrine-induced mania from an herbal diet supplement. The American Journal of Psychiatry. 1995;152(4):p. 647.", "ArticleIdList": ["7694923"]}, {"Citation": "Traboulsi A. S., Viswanathan R., Coplan J. Suicide attempt after use of herbal diet pill. American Journal of Psychiatry. 2002;159(2):318\u2013319. doi: 10.1176/appi.ajp.159.2.318.", "ArticleIdList": ["10.1176/appi.ajp.159.2.318", "11823284"]}, {"Citation": "Emmanuel N. P., Jones C., Lydiard R. B. Use of herbal products and symptoms of bipolar disorder. American Journal of Psychiatry. 1998;155(11):p. 1627.", "ArticleIdList": ["9812133"]}, {"Citation": "Corrigan F. M., Jennett J., Ernst E. Ephedra alkaloids and brief relapse in EMDR-treated obsessive compulsive disorder. Acta Psychiatrica Scandinavica. 2004;110(2):158\u2013159. doi: 10.1111/j.1600-0047.2004.00368.x.", "ArticleIdList": ["10.1111/j.1600-0047.2004.00368.x", "15233717"]}, {"Citation": "Miller S. C., Waite C. Ephedrine-type alkaloid-containing dietary supplements and substance dependence. Psychosomatics. 2003;44(6):508\u2013511. doi: 10.1176/appi.psy.44.6.508.", "ArticleIdList": ["10.1176/appi.psy.44.6.508", "14597686"]}, {"Citation": "Tinsley J. A., Watkins D. D. Over-the-counter stimulants: abuse and addiction. Mayo Clinic Proceedings. 1998;73(10):977\u2013982. doi: 10.4065/73.10.977.", "ArticleIdList": ["10.4065/73.10.977", "9787749"]}, {"Citation": "Gruber A. J., Pope H. G., Jr. Ephedrine abuse among 36 female weightlifters. The American Journal on Addictions. 1998;7(4):256\u2013261. doi: 10.3109/10550499808995637.", "ArticleIdList": ["10.3109/10550499808995637", "9809129"]}, {"Citation": "Henman A. R. Guaran\u00e1 (Paullinia cupana var. sorbilis): ecological and social perspectives on an economic plant of the central Amazon basin. Journal of Ethnopharmacology. 1982;6(3):311\u2013338. doi: 10.1016/0378-8741(82)90054-x.", "ArticleIdList": ["10.1016/0378-8741(82)90054-x", "7154700"]}, {"Citation": "Bempong D. K., Houghton P. J. Dissolution and absorption of caffeine from guarana. Journal of Pharmacy and Pharmacology. 1992;44(9):769\u2013771. doi: 10.1111/j.2042-7158.1992.tb05517.x.", "ArticleIdList": ["10.1111/j.2042-7158.1992.tb05517.x", "1360532"]}, {"Citation": "Ciszowski K., Biedron W., Gomolka E. Acute caffeine poisoning resulting in atrial fibrillation after guarana extract overdose. Przegl\u0105d Lekarski. 2014;71(9):495\u2013498.", "ArticleIdList": ["25632790"]}, {"Citation": "Benowitz N. L. Clinical pharmacology of caffeine. Annual Review of Medicine. 1990;41(1):277\u2013288. doi: 10.1146/annurev.me.41.020190.001425.", "ArticleIdList": ["10.1146/annurev.me.41.020190.001425", "2184730"]}, {"Citation": "Baghkhani L., Jafari M. Cardiovascular adverse reactions associated with Guarana: is there a causal effect? Journal of Herbal Pharmacotherapy. 2002;2(1):57\u201361. doi: 10.1300/j157v02n01_08.", "ArticleIdList": ["10.1300/j157v02n01_08", "15277107"]}, {"Citation": "Case Reports for Guarana: World Health Organization ADR database."}, {"Citation": "Galdur\u00f3z J. C., Carlini E. A. The effects of long-term administration of guarana on the cognition of normal, elderly volunteers. S\u00e3o Paulo Medical Journal. 1996;114(1):1073\u20131078. doi: 10.1590/s1516-31801996000100003.", "ArticleIdList": ["10.1590/s1516-31801996000100003", "8984582"]}, {"Citation": "Boozer C. N., Nasser J. A., Heymsfield S. B., Wang V., Chen G., Solomon J. L. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. International Journal of Obesity. 2001;25(3):316\u2013324. doi: 10.1038/sj.ijo.0801539.", "ArticleIdList": ["10.1038/sj.ijo.0801539", "11319627"]}, {"Citation": "Kucio C., Jonderko K., Piskorska D. Does yohimbine act as a slimming drug? Israel Journal of Medical Sciences. 1991;27(10):550\u2013556.", "ArticleIdList": ["1955308"]}, {"Citation": "Norris S. L., Zhang X., Avenell A., Gregg E., Schmid C. H., Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2005;(1) doi: 10.1002/14651858.CD004096.pub2.CD004096", "ArticleIdList": ["10.1002/14651858.CD004096.pub2", "PMC6718205", "15674929"]}, {"Citation": "Norris S. L., Zhang X., Avenell A., et al. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Archives of Internal Medicine. 2004;164(13):1395\u20131404. doi: 10.1001/archinte.164.13.1395.", "ArticleIdList": ["10.1001/archinte.164.13.1395", "15249348"]}, {"Citation": "Kearney T., Tu N., Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California poison control system reported cases. Annals of Pharmacotherapy. 2010;44(6):1022\u20131029. doi: 10.1345/aph.1p060.", "ArticleIdList": ["10.1345/aph.1p060", "20442348"]}, {"Citation": "Tam S. W., Worcel M., Wyllie M. Yohimbine: a clinical review. Pharmacology and Therapeutics. 2001;91(3):215\u2013243. doi: 10.1016/s0163-7258(01)00156-5.", "ArticleIdList": ["10.1016/s0163-7258(01)00156-5", "11744068"]}, {"Citation": "Ernst E., Pittler M. H. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Journal of Urology. 1998;159(2):433\u2013436. doi: 10.1016/s0022-5347(01)63942-9.", "ArticleIdList": ["10.1016/s0022-5347(01)63942-9", "9649257"]}, {"Citation": "Cameron O. G., Zubieta J. K., Grunhaus L., Minoshima S. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosomatic Medicine. 2000;62(4):549\u2013559. doi: 10.1097/00006842-200007000-00014.", "ArticleIdList": ["10.1097/00006842-200007000-00014", "10949101"]}, {"Citation": "Vasa R. A., Pine D. S., Masten C. L., et al. Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults. Psychopharmacology. 2009;204(3):445\u2013455. doi: 10.1007/s00213-009-1475-x.", "ArticleIdList": ["10.1007/s00213-009-1475-x", "PMC2740930", "19266185"]}, {"Citation": "Charney D. S., Woods S. W., Krystal J. H., Nagy L. M., Heninger G. R. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatrica Scandinavica. 1992;86(4):273\u2013282. doi: 10.1111/j.1600-0447.1992.tb03266.x.", "ArticleIdList": ["10.1111/j.1600-0447.1992.tb03266.x", "1333719"]}, {"Citation": "Charney D. S., Heninger G. R., Breier A. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry. 1984;41(8):751\u2013763. doi: 10.1001/archpsyc.1984.01790190025003.", "ArticleIdList": ["10.1001/archpsyc.1984.01790190025003", "6742977"]}, {"Citation": "Charney D. S., Woods S. W., Goodman W. K., Heninger G. R. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. The American Journal of Psychiatry. 1987;144(8):1030\u20131036. doi: 10.1176/ajp.144.8.1030.", "ArticleIdList": ["10.1176/ajp.144.8.1030", "3037926"]}, {"Citation": "Southwick S. M., Krystal J. H., Bremner J. D., et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry. 1997;54(8):749\u2013758. doi: 10.1001/archpsyc.1997.01830200083012.", "ArticleIdList": ["10.1001/archpsyc.1997.01830200083012", "9283511"]}, {"Citation": "Bremner J. D., Innis R. B., Ng C. K., et al. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Archives of General Psychiatry. 1997;54(3):246\u2013254. doi: 10.1001/archpsyc.1997.01830150070011.", "ArticleIdList": ["10.1001/archpsyc.1997.01830150070011", "9075465"]}, {"Citation": "Gurguis G. N. M., Vitton B. J., Uhde T. W. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Research. 1997;71(1):27\u201339. doi: 10.1016/S0165-1781(97)00041-3.", "ArticleIdList": ["10.1016/S0165-1781(97)00041-3", "9247979"]}, {"Citation": "Greenwald M. K., Lundahl L. H., Steinmiller C. L. Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals. Psychopharmacology. 2013;225(4):811\u2013824. doi: 10.1007/s00213-012-2868-9.", "ArticleIdList": ["10.1007/s00213-012-2868-9", "PMC3558534", "23161001"]}, {"Citation": "Stine S. M., Southwick S. M., Petrakis I. L., Kosten T. R., Charney D. S., Krystal J. H. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biological Psychiatry. 2002;51(8):642\u2013651. doi: 10.1016/s0006-3223(01)01292-6.", "ArticleIdList": ["10.1016/s0006-3223(01)01292-6", "11955464"]}, {"Citation": "Scherr M., Schwerthoeffer D., Froboese T., Castrop F., B\u00e4uml J. Psychiatric effects and side effects of the alpha-2-antagonist yohimbine: a review of literature and case report. Fortschritte der Neurologie Psychiatrie. 2009;77(10):585\u2013590. doi: 10.1055/s-0028-1109758.", "ArticleIdList": ["10.1055/s-0028-1109758", "19821221"]}, {"Citation": "Swann A. C., Lijffijt M., Lane S. D., Cox B., Steinberg J. L., Moeller F. G. Norepinephrine and impulsivity: effects of acute yohimbine. Psychopharmacology. 2013;229(1):83\u201394. doi: 10.1007/s00213-013-3088-7.", "ArticleIdList": ["10.1007/s00213-013-3088-7", "PMC3742556", "23559222"]}, {"Citation": "Swann A. C., Birnbaum D., Jagar A. A., Dougherty D. M., Moeller F. G. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biological Psychiatry. 2005;57(10):1209\u20131211. doi: 10.1016/j.biopsych.2005.02.007.", "ArticleIdList": ["10.1016/j.biopsych.2005.02.007", "15866563"]}, {"Citation": "Price L. H., Charney D. S., Heninger G. R. Three cases of manic symptoms following yohimbine administration. American Journal of Psychiatry. 1984;141(10):1267\u20131268. doi: 10.1176/ajp.141.10.1267.", "ArticleIdList": ["10.1176/ajp.141.10.1267", "6091464"]}, {"Citation": "National Center for Complementary and Alternative Medicine. Herbs at a Glance: Yohimbe. 2007.   http://nccam.nih.gov/health/yohimbe."}, {"Citation": "Jones B. D., Runikis A. M. Interaction of ginseng with phenelzine. Journal of Clinical Psychopharmacology. 1987;7(3):201\u2013202. doi: 10.1097/00004714-198706000-00030.", "ArticleIdList": ["10.1097/00004714-198706000-00030", "3597812"]}, {"Citation": "Shader R. I., Greenblatt D. J. Phenelzine and the dream machine\u2014ramblings and reflections. Journal of Clinical Psychopharmacology. 1985;5(2):p. 65. doi: 10.1097/00004714-198504000-00001.", "ArticleIdList": ["10.1097/00004714-198504000-00001", "3988971"]}, {"Citation": "Shader R. I., Greenblatt D. J. Bees, ginseng and MAOIs revisited. Journal of Clinical Psychopharmacology. 1988;8(4):p. 235.", "ArticleIdList": ["3209715"]}, {"Citation": "Nikaido T., Ohmoto T., Sankawa U. Inhibitors of cyclic AMP phosphodiesterase in Panax ginseng C. A. Meyer and Panax japonicus C. A. Meyer. Chemical and Pharmaceutical Bulletin. 1984;32(4):1477\u20131483. doi: 10.1248/cpb.32.1477.", "ArticleIdList": ["10.1248/cpb.32.1477", "6088096"]}, {"Citation": "Hodges P. J., Kam P. C. A. The peri-operative implications of herbal medicines. Anaesthesia. 2002;57(9):889\u2013899. doi: 10.1046/j.1365-2044.2002.02781.x.", "ArticleIdList": ["10.1046/j.1365-2044.2002.02781.x", "12190754"]}, {"Citation": "Dawson J. K., Earnshaw S. M., Graham C. S. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. Journal of Accident and Emergency Medicine. 1995;12(1):49\u201351. doi: 10.1136/emj.12.1.49.", "ArticleIdList": ["10.1136/emj.12.1.49", "PMC1342519", "7640830"]}, {"Citation": "Wilkinson G. R. Drug metabolism and variability among patients in drug response. The New England Journal of Medicine. 2005;352(21):2211\u20132221. doi: 10.1056/nejmra032424.", "ArticleIdList": ["10.1056/nejmra032424", "15917386"]}, {"Citation": "Bersani F. S., Capra E., Minichino A., et al. Factors affecting interindividual differences in clozapine response: a review and case report. Human Psychopharmacology. 2011;26(3):177\u2013187. doi: 10.1002/hup.1191.", "ArticleIdList": ["10.1002/hup.1191", "21455971"]}, {"Citation": "Carrillo J. A., Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clinical Pharmacokinetics. 2000;39(2):127\u2013153. doi: 10.2165/00003088-200039020-00004.", "ArticleIdList": ["10.2165/00003088-200039020-00004", "10976659"]}, {"Citation": "H\u00e4gg S., Spigset O., Mj\u00f6rndal T., Dahlqvist R. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology. 2000;49(1):59\u201363. doi: 10.1046/j.1365-2125.2000.00111.x.", "ArticleIdList": ["10.1046/j.1365-2125.2000.00111.x", "PMC2014893", "10606838"]}, {"Citation": "Williamson E. M. Drug interactions between herbal and prescription medicines. Drug Safety. 2003;26(15):1075\u20131092. doi: 10.2165/00002018-200326150-00002.", "ArticleIdList": ["10.2165/00002018-200326150-00002", "14640772"]}, {"Citation": "Mester R., Toren P., Mizrachi I., Wolmer L., Karni N., Weizman A. Caffeine withdrawal increases lithium blood levels. Biological Psychiatry. 1995;37(5):348\u2013350. doi: 10.1016/0006-3223(94)00243-V.", "ArticleIdList": ["10.1016/0006-3223(94)00243-V", "7748990"]}, {"Citation": "Holmberg G., Gershon S. Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia. 1961;2(2):93\u2013106. doi: 10.1007/BF00592678.", "ArticleIdList": ["10.1007/BF00592678", "13715444"]}, {"Citation": "Lacomblez L., Bensimon G., Isnard F., Diquet B., Lecrubier Y., Puech A. J. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clinical Pharmacology & Therapeutics. 1989;45(3):241\u2013251. doi: 10.1038/clpt.1989.24.", "ArticleIdList": ["10.1038/clpt.1989.24", "2920499"]}, {"Citation": "Lecrubier Y., Puech A. J., Des Lauriers A. Favourable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study. British Journal of Clinical Pharmacology. 1981;12(1):90\u201393. doi: 10.1111/j.1365-2125.1981.tb01863.x.", "ArticleIdList": ["10.1111/j.1365-2125.1981.tb01863.x", "PMC1401742", "7018547"]}, {"Citation": "Quinton R. M. The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice. British Journal of Pharmacology and Chemotherapy. 1963;21:51\u201366. doi: 10.1111/j.1476-5381.1963.tb01501.x.", "ArticleIdList": ["10.1111/j.1476-5381.1963.tb01501.x", "PMC1703860", "14066151"]}, {"Citation": "Dhir A., Kulkarni S. K. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology. 2007;80(4):239\u2013243. doi: 10.1159/000104877.", "ArticleIdList": ["10.1159/000104877", "17622775"]}, {"Citation": "Pal S., Khossousi A., Binns C., Dhaliwal S., Ellis V. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. British Journal of Nutrition. 2011;105(1):90\u2013100. doi: 10.1017/S0007114510003132.", "ArticleIdList": ["10.1017/S0007114510003132", "20727237"]}, {"Citation": "Fong S. Y. K., Gao Q., Zuo Z. Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2013;2013:15. doi: 10.1155/2013/898261.898261", "ArticleIdList": ["10.1155/2013/898261", "PMC3760091", "24023584"]}, {"Citation": "Perlman B. B. Interaction between lithium salts and ispaghula husk. The Lancet. 1990;335(8686):p. 416.", "ArticleIdList": ["1968148"]}, {"Citation": "Panossian A., Wikman G., Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481\u2013493. doi: 10.1016/j.phymed.2010.02.002.", "ArticleIdList": ["10.1016/j.phymed.2010.02.002", "20378318"]}, {"Citation": "Khanum F., Bawa A. S., Singh B. Rhodiola rosea: a versatile adaptogen. Comprehensive Reviews in Food Science and Food Safety. 2005;4(3):55\u201362. doi: 10.1111/j.1541-4337.2005.tb00073.x.", "ArticleIdList": ["10.1111/j.1541-4337.2005.tb00073.x", "33430554"]}, {"Citation": "Kwon Y.-I., Jang H.-D., Shetty K. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension. Asia Pacific Journal of Clinical Nutrition. 2006;15(3):425\u2013432.", "ArticleIdList": ["16837437"]}, {"Citation": "Maniscalco I., Toffol E., Giupponi G., Conca A. The interaction of Rhodiola rosea and antidepressants. A case report. Neuropsychiatrie. 2015;29(1):36\u201338. doi: 10.1007/s40211-014-0124-8.", "ArticleIdList": ["10.1007/s40211-014-0124-8", "25413939"]}, {"Citation": "Chevassus H., Gaillard J.-B., Farret A., et al. A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects. European Journal of Clinical Pharmacology. 2010;66(5):449\u2013455. doi: 10.1007/s00228-009-0770-0.", "ArticleIdList": ["10.1007/s00228-009-0770-0", "20020282"]}, {"Citation": "J\u00e4ger A. K., Gauguin B., Andersen J., Adsersen A., Gudiksen L. Screening of plants used in Danish folk medicine to treat depression and anxiety for affinity to the serotonin transporter and inhibition of MAO-A. Journal of Ethnopharmacology. 2013;145(3):822\u2013825. doi: 10.1016/j.jep.2012.12.021.", "ArticleIdList": ["10.1016/j.jep.2012.12.021", "23266274"]}, {"Citation": "Wang J., Chen B., Yao S. Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electrospray ionization-MS. Food Additives and Contaminants Part A: Chemistry, Analysis, Control, Exposure and Risk Assessment. 2008;25(7):822\u2013830. doi: 10.1080/02652030801946553.", "ArticleIdList": ["10.1080/02652030801946553", "18569001"]}, {"Citation": "Chang K., Mak T. W. L., Kwong L., So K. T. Valvular heart disease caused by Chinese proprietary slimming medicine adulterated with fenfluramine. Hong Kong Journal of Paediatrics. 2005;(10):55\u201358."}, {"Citation": "Garges H. P., Varia I., Doraiswamy P. M. Cardiac complications and delirium associated with valerian root withdrawal. The Journal of the American Medical Association. 1998;280(18):1566\u20131567. doi: 10.1001/jama.280.18.1566.", "ArticleIdList": ["10.1001/jama.280.18.1566", "9820254"]}, {"Citation": "Kennedy D. O., Scholey A. B., Tildesley N. T. J., Perry E. K., Wesnes K. A. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacology Biochemistry and Behavior. 2002;72(4):953\u2013964. doi: 10.1016/s0091-3057(02)00777-3.", "ArticleIdList": ["10.1016/s0091-3057(02)00777-3", "12062586"]}, {"Citation": "Florentin M., Liberopoulos E. N., Elisaf M. S. Sibutramine-associated adverse effects: a practical guide for its safe use. Obesity Reviews. 2008;9(4):378\u2013387. doi: 10.1111/j.1467-789x.2007.00425.x.", "ArticleIdList": ["10.1111/j.1467-789x.2007.00425.x", "18034790"]}, {"Citation": "Barnes D. M. Neurotoxicity creates regulatory dilemma. Science. 1989;243(4887):29\u201330. doi: 10.1126/science.2911718.", "ArticleIdList": ["10.1126/science.2911718", "2911718"]}, {"Citation": "Roca R. P., Blackman M. R., Ackerley M. B., Harman S. M., Gregerman R. I. Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocrine Research. 1990;16(4):415\u2013447. doi: 10.1080/07435809009107116.", "ArticleIdList": ["10.1080/07435809009107116", "2129342"]}, {"Citation": "Bent S., Padula A., Moore D., Patterson M., Mehling W. Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine. 2006;119(12):1005\u20131012. doi: 10.1016/j.amjmed.2006.02.026.", "ArticleIdList": ["10.1016/j.amjmed.2006.02.026", "PMC4394901", "17145239"]}, {"Citation": "Ulbricht C., Brendler T., Gruenwald J., et al. Lemon balm (Melissa officinalis L.): an evidence-based systematic review by the natural standard research collaboration. Journal of Herbal Pharmacotherapy. 2005;5(4):71\u2013114. doi: 10.1300/j157v05n04_08.", "ArticleIdList": ["10.1300/j157v05n04_08", "16635970"]}, {"Citation": "Dhawan K., Dhawan S., Sharma A. Passiflora: a review update. Journal of Ethnopharmacology. 2004;94(1):1\u201323. doi: 10.1016/j.jep.2004.02.023.", "ArticleIdList": ["10.1016/j.jep.2004.02.023", "15261959"]}, {"Citation": "Cerny A., Schmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study) Fitoterapia. 1999;70(3):221\u2013228. doi: 10.1016/S0367-326X(99)00018-0.", "ArticleIdList": ["10.1016/S0367-326X(99)00018-0"]}, {"Citation": "Kennedy D. O., Wake G., Savelev S., et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28(10):1871\u20131881. doi: 10.1038/sj.npp.1300230.", "ArticleIdList": ["10.1038/sj.npp.1300230", "12888775"]}, {"Citation": "Solbakken A. M., Rorbakken G., Gundersen T. Nature medicine as intoxicant. Tidsskrift for Den Norske Legeforening. 1997;117(8):1140\u20131141.", "ArticleIdList": ["9148484"]}, {"Citation": "Soulimani R., Fleurentin J., Mortier F., Misslin R., Derrieu G., Pelt J.-M. Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta Medica. 1991;57(2):105\u2013109. doi: 10.1055/s-2006-960042.", "ArticleIdList": ["10.1055/s-2006-960042", "1891490"]}, {"Citation": "Ernst E., Rand J. I., Barnes J., Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatumL.) European Journal of Clinical Pharmacology. 1998;54(8):589\u2013594. doi: 10.1007/s002280050519.", "ArticleIdList": ["10.1007/s002280050519", "9860144"]}, {"Citation": "Bowery N. G., Smart T. G. GABA and glycine as neurotransmitters: a brief history. British Journal of Pharmacology. 2006;147(supplement 1):S109\u2013S119. doi: 10.1038/sj.bjp.0706443.", "ArticleIdList": ["10.1038/sj.bjp.0706443", "PMC1760744", "16402094"]}, {"Citation": "Carrasco M. C., Vallejo J. R., Pardo-de-Santayana M., Peral D., Mart\u00edn M. \u00c1., Altimiras J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytotherapy Research. 2009;23(12):1795\u20131796. doi: 10.1002/ptr.2847.", "ArticleIdList": ["10.1002/ptr.2847", "19441067"]}, {"Citation": "Izzo A. A. Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence. International Journal of Clinical Pharmacology and Therapeutics. 2004;42(3):139\u2013148. doi: 10.5414/cpp42139.", "ArticleIdList": ["10.5414/cpp42139", "15049433"]}, {"Citation": "Torres S. J., Nowson C. A. Relationship between stress, eating behavior, and obesity. Nutrition. 2007;23(11-12):887\u2013894. doi: 10.1016/j.nut.2007.08.008.", "ArticleIdList": ["10.1016/j.nut.2007.08.008", "17869482"]}, {"Citation": "Brown R. P., Gerbarg P. L. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. Journal of Psychiatric Practice. 2001;7(2):75\u201391. doi: 10.1097/00131746-200103000-00002.", "ArticleIdList": ["10.1097/00131746-200103000-00002", "15990509"]}, {"Citation": "Gonnissen H. K. J., Adam T. C., Hursel R., Rutters F., Verhoef S. P. M., Westerterp-Plantenga M. S. Sleep duration, sleep quality and body weight: parallel developments. Physiology and Behavior. 2013;121:112\u2013116. doi: 10.1016/j.physbeh.2013.04.007.", "ArticleIdList": ["10.1016/j.physbeh.2013.04.007", "23643826"]}, {"Citation": "Bersani F. S., Iannitelli A., Pacitti F., Bersani G. Sleep and biorythm disturbances in schizophrenia, mood and anxiety disorders: a review. Rivista di Psichiatria. 2012;47(5):365\u2013375.", "ArticleIdList": ["23160047"]}, {"Citation": "Ulbricht C., Basch E., Weissner W., Hackman D. An evidence-based systematic review of herb and supplement interactions by the natural standard research collaboration. Expert Opinion on Drug Safety. 2006;5(5):719\u2013728. doi: 10.1517/14740338.5.5.719.", "ArticleIdList": ["10.1517/14740338.5.5.719", "16907661"]}, {"Citation": "Simon G. E., Von Korff M., Saunders K., et al. Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry. 2006;63(7):824\u2013830. doi: 10.1001/archpsyc.63.7.824.", "ArticleIdList": ["10.1001/archpsyc.63.7.824", "PMC1913935", "16818872"]}, {"Citation": "Biondi M., Bersani F. S., Valentini M. The Italian edition of DSM-5. Rivista di Psichiatria. 2014;49(2):57\u201360. doi: 10.1708/1461.16137.", "ArticleIdList": ["10.1708/1461.16137", "24770570"]}, {"Citation": "Enna S. J., Norton S. Herbal Supplements and the Brain: Understanding Their Health Benefits and Hazards. Upper Saddle River, NJ, USA: Pearson Education; 2010."}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "5", "Day": "28"}, {"Year": "2015", "Month": "8", "Day": "2"}, {"Year": "2015", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "9", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26457296", "PMC4589574", "10.1155/2015/120679"]}}], "PubmedBookArticle": []}